Leigh Turner is the Executive Director of the University of California, Irvine’s Bioethics Program and a Professor in the Program in Public Health’s Department of Health, Society, and Behavior. He is also a member of UCI’s Stem Cell Research Center and serves as Ethics Lead for UCI’s Institute for Clinical and Translational Science. Turner’s current research addresses ethical, legal, and social issues related to stem cells and regenerative medicine products. In particular, he uses approaches from health ethics and the social sciences to study the activities of clinics engaged in direct-to-consumer marketing of unproven and unlicensed cell-based interventions. He has also written about ethical dimensions of health-related travel, crowdfunding for medical interventions, and end-of-life care in multicultural societies. Turner is a member of the International Society for Cell & Gene Therapy’s Committee on the Ethics of Cell and Gene Therapy and ISCT’s Expanded Access Working Group